YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway. - Wikidata - wikimedia - TriplyDB

YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway.

YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway.

http://www.wikidata.org/entity/Q39672848

about

Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?Functional impact of ABCB1 variants on interactions between P-glycoprotein and methadone Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1 The functional influences of common ABCB1 genetic variants on the inhibition of P-glycoprotein by Antrodia cinnamomea extracts Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells.

P2860

Q28069761-592900BC-B6B6-490A-855B-F0B6C3DCFDE4 Q28488223-F6663CF0-39CC-4609-8B82-F8F22CF9B013 Q28535627-F1B70DC0-F170-4F19-A99C-AD8B521F002B Q33821469-AA10C6B6-184F-4C07-8140-C8DDCBB3C6C3 Q34118293-6671B921-D861-4809-BA0D-420C92FC24E8 Q34402422-99691262-5F1E-43AC-9BBF-D2330DE89815 Q35107752-4D94B99D-629D-4FCF-AA31-7E97B9432C2B Q38011895-71E64390-05BD-4A38-8E3F-05A8AAEDC4C8

P2860

YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway.

http://www.wikidata.org/entity/Q39672848

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

YC-1, a novel potential antica ...... in via cGMP-dependent pathway.

@en

YC-1, a novel potential antica ...... in via cGMP-dependent pathway.

@nl

type

label

YC-1, a novel potential antica ...... in via cGMP-dependent pathway.

@en

YC-1, a novel potential antica ...... in via cGMP-dependent pathway.

@nl

prefLabel

YC-1, a novel potential antica ...... in via cGMP-dependent pathway.

@en

YC-1, a novel potential antica ...... in via cGMP-dependent pathway.

@nl

P1433

Q39672848-D3A570BE-BCF7-4388-AAA2-BE9C4F759AEF

P1476

Q39672848-43FCA46C-01B7-411B-BAF6-615C9C788072

P2093

Q39672848-43C6EC66-AE1C-41E5-A02E-C975EBF6DAAC

P2860

Q39672848-0480CE9D-FECD-43B2-A8E5-33D0B4927D43

Q39672848-09BC88D9-6F1F-4154-8B82-4409FACBA4C7

Q39672848-0F188AFF-C004-4501-B967-3045A6486D23

Q39672848-1175CF77-C84F-49E6-8E24-505E1FF761FF

Q39672848-2298A45A-F640-4CF3-8DD3-7F9BCD3769EA

Q39672848-23058F30-4C23-4B48-981A-73BFA8F34422

Q39672848-2B558C3A-EDA3-4B4E-BF9A-065DE392B2D8

Q39672848-2C098E4B-75F4-49F6-95A8-6E5FE15911F6

Q39672848-390E3C28-890F-47E1-A1FC-08160B4B95BE

Q39672848-3F8DE340-D089-4FA9-9D6B-A66F6B5E843C

P2888

Q39672848-772BECF3-A74E-4944-8356-544E92F319D7

P304

Q39672848-25EB9A1D-1A23-4C96-A4BA-65802E67E024

P31

Q39672848-114B01D5-DC15-4D03-838E-8CBAB3D1E0E5

P356

Q39672848-61D56015-8608-454E-B6B2-157E70A20867

P433

Q39672848-41A19D59-222F-460C-9CA1-1AAC3E0ADD3C

P478

Q39672848-BEDD5F7B-99D6-4BFA-8B8B-35CC8A080466

P50

Q39672848-1371FCE6-EC9A-45D8-8B97-44847FDDCDA4

P577

Q39672848-14B655E4-1910-409E-848A-A695FD953662

P698

Q39672848-5A799EAF-DE63-4747-8CA4-B9E3B0310236

P921

Q39672848-CA6AD523-35E1-471F-9037-6CE3D91BC775

P356

S10637-010-9496-1

P1433

Investigational New Drugs

P1476

YC-1, a novel potential antica ...... ein via cGMP-dependent pathway

@en

P2093

Chin-Chuan Hung

http://www.w3.org/2001/XMLSchema#string

P2860

ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells

The multidrug resistance protein family.

Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase

Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.

Nitric oxide and cell death.

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

Drug resistance in brain diseases and the role of drug efflux transporters.

Multidrug resistance transporters and modulation.

Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies.

P2888

s10637-010-9496-1

P304

1337-1346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10637-010-9496-1

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Horng-huei Liou

P577

2010-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20676745

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance